Background: Personality dysfunction represents one of the only predictors of differential response between active treatments for depression to have replicated. In this study, we examine whether depressed patients with higher neuroticism scores, a marker of personality dysfunction, show differences versus depressed patients with lower scores in the functioning of two brain regions associated with treatment response, the anterior cingulate and anterior insula cortices.

Methods: Functional magnetic resonance imaging data during an emotional Stroop task were collected from 135 adults diagnosed with major depressive disorder at four academic medical centers participating in the Establishing Moderators and Biosignatures of Antidepressant Response for Clinical Care (EMBARC) study. Secondary analyses were conducted including a sample of 28 healthy individuals.

Results: In whole-brain analyses, higher neuroticism among depressed adults was associated with increased activity in and connectivity with the right anterior insula cortex to incongruent compared to congruent emotional stimuli (ks>281, s<0.05 FWE corrected), covarying for concurrent psychiatric distress. We also observed an unanticipated relationship between neuroticism and reduced activity in the precuneus (k=269, <0.05 FWE corrected). Exploratory analyses including healthy individuals suggested that associations between neuroticism and brain function may be nonlinear over the full range of neuroticism scores.

Conclusions: This study provides convergent evidence for the importance of the right anterior insula cortex as a brain-based marker of clinically meaningful individual differences in neuroticism among adults with depression. This is a critical next step in linking personality dysfunction, a replicated clinical predictor of differential antidepressant treatment response, with differences in underlying brain function.

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5624319PMC
http://dx.doi.org/10.1016/j.bpsc.2016.11.008DOI Listing

Publication Analysis

Top Keywords

embarc study
8
personality dysfunction
8
depressed patients
8
higher neuroticism
8
anterior insula
8
neuroticism individual
4
individual differences
4
differences neural
4
neural function
4
function unmedicated
4

Similar Publications

Background: The serum antiglycopeptidolipid core IgA antibody test has been proposed as a diagnostic tool for Mycobacterium avium complex pulmonary diseases. Cross-reactivity with other nontuberculous mycobacteria (NTM), including Mycobacterium abscessus, indicates that it may have a role as a broader screening test for nontuberculous mycobacterial pulmonary disease (NTM-PD). NTM-PD is believed to be underdiagnosed in patients with bronchiectasis.

View Article and Find Full Text PDF

Background: Aspergillus species cause diverse clinical manifestations in bronchiectasis including allergic bronchopulmonary aspergillosis (ABPA), Aspergillus sensitization (AS), and raised IgG indicating exposure to or infection with Aspergillus.

Research Question: What are the prevalence and clinical significance of Aspergillus-associated conditions in individuals with bronchiectasis?

Study Design And Methods: Patients with bronchiectasis enrolled into the European Bronchiectasis Registry from 2015 through 2022 with laboratory testing for Aspergillus lung disease (total IgE, IgE specific to Aspergillus or Aspergillus skin test, or IgG specific to Aspergillus and blood eosinophil counts) were included for analysis. Modified International Society for Human and Anima Mycology ABPA working group criteria (2021) were used to define ABPA.

View Article and Find Full Text PDF

Epidemiology of bronchiectasis.

Eur Respir Rev

October 2024

Pneumology Department, Hospital Universitari Vall d'Hebron, Vall d'Hebron Institut de Recerca (VHIR), Vall d'Hebron Barcelona Hospital Campus, CIBERES, Barcelona, Spain.

Article Synopsis
  • Bronchiectasis is a chronic lung condition marked by the permanent widening of airways, leading to symptoms like cough and sputum production, with rising global incidence possibly linked to better imaging and awareness.
  • Recent studies show a significant increase in mortality rates among bronchiectasis patients, ranging from 16-24.8% over 4-5 years, though prevalence data can vary widely, indicating possible underreporting and methodological issues in research.
  • This review aims to summarize current epidemiological data on bronchiectasis, including its incidence, prevalence, mortality, healthcare costs, and factors affecting its distribution across different geographic areas.
View Article and Find Full Text PDF

Objective: Predicting an individual's response to antidepressant medication remains one of the most challenging tasks in the treatment of major depressive disorder (MDD). Our objective was to use the large EMBARC study database to develop an electroencephalography (EEG)-based method to predict response to antidepressant treatment.

Methods: Pre-treatment EEG data were collected from study participants treated with either sertraline (N = 105), placebo (N = 119), or bupropion (N = 35).

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!